Clinical Trial Update: A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates several radiation dose levels for patients whose cancers progressed on immunotherapy/checkpoint inhibitors, spanning mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Head and Neck Cancer
• Kidney Cancer
• Lung Cancer
• Melanoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Cancer, Melanoma Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING